Episode Parent: The Niche Pod

Vaccines are here, capitalizing on capital with IPOs, and Gilead targets Hepatitis D. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19https://www.abcellera.com/news/2020-12-10-abcellera-announces-pricing-of-ipohttps://www.certara.com/pressrelease/certara-announces-pricing-of-its-upsized-initial-public-offering/https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4d-molecular-therapeutics-announces-upsized-pricing-initialhttps://www.nanobiotix.com/wp-content/uploads/2020/12/PR-Pricing.pdfhttps://www.gilead.com/news-and-press/press-room/press-releases/2020/12/gilead-sciences-to-acquire-myr-gmbh Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson  The Niche Podcast brings you…

Everlywell expands at-home testing, Bayer and Atara strike deal, and Moderna heads to the FDA. Sponsors https://www.thescopemethod.com Story References https://www.prnewswire.com/news-releases/everlywell-announces-175-million-financing-to-expand-consumer-lab-testing-and-digital-health-offerings-301185355.html https://media.bayer.com/baynews/baynews.nsf/id/Bayer-Atara-Biotherapeutics-enter-strategic-collaboration-generation-mesothelin-targeted-CAR-T?Open&parent=news-overview-category-search-en&ccm=020 https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study Music by Luke…

This week, we take a thanksgiving break from the news cycle to bring you a special interview with a COVID survivor and healthcare worker, Trenton…

Pfizer submits to the FDA, how mRNA vaccines work, and Novartis drops a billion, but really only $50 million Story Referenceshttps://www.biospace.com/article/pfizer-and-biontech-to-submit-covid-19-vaccine-to-fda-for-emergency-use-today/https://www.biospace.com/article/releases/stoke-therapeutics-announces-pricing-of-97-5-million-public-offering/https://www.novartis.com/news/media-releases/novartis-secures-exclusive-rights-potential-acute-respiratory-distress-syndrome-cell-therapy  Sponsorshttps://www.thescopemethod.com The Niche Podcast…

COVID19 vaccine news, an app to stop nightmares, Agios targets Sickle Cell disease, and Silverback files to go public. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-againsthttps://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacyhttps://night-ware.com/newshttps://investor.agios.com/news-releases/news-release-details/agios-announces-fda-orphan-drug-designation-granted-mitapivat-0https://sec.report/Document/0001193125-20-290236/ Music by Luke…

Aducanumab skeptics, Novo Nordisk and Merck make acquisitions, but first a market update. Sponsorshttps://www.thescopemethod.com   Story References https://www.sciencemag.org/news/2020/11/biogen-s-alzheimer-s-drug-candidate-takes-beating-fda-advisershttps://www.merck.com/news/merck-announces-third-quarter-2020-financial-results/https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=33374 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson The Niche Podcast…

Syneos Health acquires Synteract, Apellis strikes a billion-dollar deal, and clinical trial patient enrollment, but first a market update. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.investor.syneoshealth.com/news-releases/news-release-details/syneos-health-acquire-synteract-top-cro-provider-emerginghttps://www.prnewswire.com/news-releases/new-greenphire-data-indicates-clinical-trial-industrys-swift-rebound-patient-enrollment-reaches-pre-pandemic-levels-301159557.html?tc=eml_cleartimehttps://investors.apellis.com/news-releases/news-release-details/apellis-and-sobi-enter-collaboration-global-co-development-and  Music by Luke…

This week, siteless with vision, IQVIA back on track, 36%, convalescent plasma, and Remdesivir approved. Sponsors https://www.thescopemethod.com   Story References https://www.businesswire.com/news/home/20201020005645/en/LabCorp-Transforms-the-Clinical-Trial-Experience-And-Streamlines-the-Drug-Development-Process https://www.businesswire.com/news/home/20201020005345/en/IQVIA-Reports-Third-Quarter-2020-Results-Raises-Full-Year-2020-Guidance-and-Provides-2021-Outlook https://www.prnewswire.com/news-releases/thermo-fisher-scientific-reports-third-quarter-2020-results-301156312.html https://www.bmj.com/content/371/bmj.m3939 https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 …

Failures in sickle-cell therapy, CRO mergers in Asia, Praxis IPO, and wasp venom. Sponsors https://www.thescopemethod.com Story References https://ir.cyclerion.com/news-releases/news-release-details/cyclerion-announces-phase-2-strong-scd-study-results-patients https://ir.cyclerion.com/news-releases/news-release-details/cyclerion-announces-positive-data-iw-6463-cns-translational https://novotech-cro.com/news/asia-pacific-has-record-year-clinical-trials-according-novotech  https://investors.praxismedicines.com/press-releases https://www.pnas.org/content/early/2020/10/07/2012379117 Music by Luke…

Nobel prizes, clinical trials for tinnitus, Takeda’s billion-dollar deal, and the White House keeps science political Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.nobelprize.org/prizes/chemistry/2020/summary/https://stm.sciencemag.org/content/12/564/eabb2830https://www.nytimes.com/2020/10/05/us/politics/coronavirus-vaccine-guidelines.htmlhttps://www.businesswire.com/news/home/20201008005340/en/ Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson The Niche…